Related Experiment Video
Updated: Sep 26, 2026

A Novel Method: Super-selective Adrenal Venous Sampling
Published on: September 15, 2017
Aberrant receptor-mediated Cushing's syndrome
Xavier Bertagna1, Lionel Groussin, Jean-Pierre Luton
1Service des Maladies Endocriniennes et Métaboliques, Hôspital Cochin, Paris, France. xavier.bertagna@cch.ap-hop-paris.fr
Abstract:
Multiple alterations of G-protein-coupled receptors and G-proteins regulating intracellular transduction signal have been described in endocrine tumours. In Cushing's syndrome, aberrant or 'illicit' expression of membrane receptors (mainly G-protein-coupled receptors) has been observed in adrenal adenomas and adrenocorticotropic hormone (ACTH)-independent macronodular bilateral adrenal hyperplasia. The best characterized example to date is the aberrant expression of the gastric inhibitory polypeptide receptor that causes 'food-dependent hypercortisolism'. Aberrant expression of the luteinizing hormone, 2-adrenergic, interleukin receptors have also been reported. The level of expression of the vasopressin V1a receptor correlates with the direct (ACTH-independent) cortisol response to vasopressin.
Insights
Aberrant G-protein-coupled receptor expression in endocrine tumors, like Cushing's syndrome, drives abnormal cortisol production. This includes food-dependent hypercortisolism linked to specific receptor alterations.
Area of Science:
- Endocrinology
- Molecular Biology
- Oncology
Background:
- G-protein-coupled receptors (GPCRs) and G-proteins are crucial for intracellular signaling in endocrine tissues.
- Alterations in these pathways are implicated in the development of endocrine tumors.
- Aberrant receptor expression is a known factor in adrenal adenomas and ACTH-independent macronodular bilateral adrenal hyperplasia.
Purpose of the Study:
- To investigate the role of aberrant G-protein-coupled receptor expression in endocrine tumors, particularly Cushing's syndrome.
- To identify specific receptors involved in abnormal cortisol production.
- To understand the correlation between receptor expression levels and clinical manifestations.
Main Methods:
- Analysis of G-protein-coupled receptor expression in endocrine tumor tissues.
- Investigating the signaling pathways regulated by these receptors.
- Correlating receptor expression levels with hormone production and clinical data.
Main Results:
- Documented multiple alterations of GPCRs and G-proteins in endocrine tumors.
- Observed aberrant expression of membrane receptors, including GPCRs, in adrenal adenomas and ACTH-independent macronodular bilateral adrenal hyperplasia.
- Identified aberrant gastric inhibitory polypeptide receptor expression as a cause of food-dependent hypercortisolism.
- Reported aberrant expression of luteinizing hormone, 2-adrenergic, and interleukin receptors.
- Found that vasopressin V1a receptor expression levels correlate with ACTH-independent cortisol response to vasopressin.
Conclusions:
- Aberrant G-protein-coupled receptor expression is a significant mechanism in endocrine tumorigenesis and hormone dysregulation.
- Specific receptor alterations, such as the gastric inhibitory polypeptide receptor, lead to distinct clinical syndromes like food-dependent hypercortisolism.
- Further research into these aberrant receptors may reveal novel therapeutic targets for endocrine disorders.
Related Concept Videos
Cushing Syndrome I: Introduction
Cushing Syndrome II: Pathophysiology
Abnormal Proliferation
Abnormal Proliferation
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
GPCRs Regulate Adenylyl Cylase Activity
Two...